Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Originally published in Science Express on 21 June 2007
Science 27 July 2007:
Vol. 317. no. 5837, pp. 516 - 519
DOI: 10.1126/science.1143780
Prev | Table of Contents | Next

Reports

Sirtuin 2 Inhibitors Rescue {alpha}-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

Tiago Fleming Outeiro,1,2 Eirene Kontopoulos,3* Stephen M. Altmann,2* Irina Kufareva,4 Katherine E. Strathearn,5 Allison M. Amore,2 Catherine B. Volk,5 Michele M. Maxwell,2 Jean-Christophe Rochet,5 Pamela J. McLean,1,2 Anne B. Young,2 Ruben Abagyan,4 Mel B. Feany,3 Bradley T. Hyman,1,2 Aleksey G. Kazantsev2{dagger}

The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging. We identified a potent inhibitor of sirtuin 2 (SIRT2) and found that inhibition of SIRT2 rescued {alpha}-synuclein toxicity and modified inclusion morphology in a cellular model of Parkinson's disease. Genetic inhibition of SIRT2 via small interfering RNA similarly rescued {alpha}-synuclein toxicity. Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease. The results suggest a link between neurodegeneration and aging.

1 Alzheimer's Research Unit, MGH, Harvard Medical School, CNY 114, 16th Street, Charlestown, MA 02129, USA.
2 Mass General Institute for Neurodegenerative Disease, MGH, Harvard Medical School, CNY 114, 16th Street, Charlestown, MA 02129, USA.
3 Harvard Medical School and Brigham and Women's Hospital, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Harvard New Research Building, Room 630, 77 Louis Pasteur Avenue, Boston, MA 02115, USA.
4 Department of Molecular Biology, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
5 Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA.

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: akazantsev{at}partners.org

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Emerging Characterization of Lysine Residue Deacetylation on the Modulation of Mitochondrial Function and Cardiovascular Biology.
Z. Lu, I. Scott, B. R. Webster, and M. N. Sack (2009)
Circ. Res. 105, 830-841
   Abstract »    Full Text »    PDF »
Calorie restriction and the exercise of chromatin.
A. Vaquero and D. Reinberg (2009)
Genes & Dev. 23, 1849-1869
   Abstract »    Full Text »    PDF »
The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons.
J. Chang, R. H. Baloh, and J. Milbrandt (2009)
J. Cell Sci. 122, 2274-2282
   Abstract »    Full Text »    PDF »
Epigenetics in cancer: Targeting chromatin modifications.
L. Ellis, P. W. Atadja, and R. W. Johnstone (2009)
Mol. Cancer Ther. 8, 1409-1420
   Abstract »    Full Text »    PDF »
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.
J. Pallos, L. Bodai, T. Lukacsovich, J. M. Purcell, J. S. Steffan, L. M. Thompson, and J. L. Marsh (2008)
Hum. Mol. Genet. 17, 3767-3775
   Abstract »    Full Text »    PDF »
Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau.
K. N. Green, J. S. Steffan, H. Martinez-Coria, X. Sun, S. S. Schreiber, L. M. Thompson, and F. M. LaFerla (2008)
J. Neurosci. 28, 11500-11510
   Abstract »    Full Text »    PDF »
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1.
H. Catoire, M. Y. Pasco, A. Abu-Baker, S. Holbert, C. Tourette, B. Brais, G. A. Rouleau, J. A. Parker, and C. Neri (2008)
Hum. Mol. Genet. 17, 2108-2117
   Abstract »    Full Text »    PDF »
Quantitative Proteomics of a Presymptomatic A53T {alpha}-Synuclein Drosophila Model of Parkinson Disease.
Z. Xun, R. A. Sowell, T. C. Kaufman, and D. E. Clemmer (2008)
Mol. Cell. Proteomics 7, 1191-1203
   Abstract »    Full Text »    PDF »
Monoubiquitylation of {alpha}-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells.
R. Rott, R. Szargel, J. Haskin, V. Shani, A. Shainskaya, I. Manov, E. Liani, E. Avraham, and S. Engelender (2008)
J. Biol. Chem. 283, 3316-3328
   Abstract »    Full Text »    PDF »
Possible New Treatment Strategy for Parkinson Disease.
(2007)
Journal Watch (General) 2007, 3
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)